138 related articles for article (PubMed ID: 38471150)
1. Current development of theragnostic nanoparticles for women's cancer treatment.
Kashyap A; Kumari M; Singh A; Mukherjee K; Maity D
Biomed Mater; 2024 May; 19(4):. PubMed ID: 38471150
[TBL] [Abstract][Full Text] [Related]
2. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
3. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
4. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
5. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
6. Zwitterionic Polymer-Gated Au@TiO
Zheng T; Wang W; Wu F; Zhang M; Shen J; Sun Y
Theranostics; 2019; 9(17):5035-5048. PubMed ID: 31410200
[TBL] [Abstract][Full Text] [Related]
7. Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.
Li X; Zou Q; Zhang J; Zhang P; Zhou X; Yalamarty SSK; Liang X; Liu Y; Zheng Q; Gao J
Int J Nanomedicine; 2020; 15():6791-6811. PubMed ID: 32982234
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional theranostic nanosystems enabling photothermal-chemo combination therapy of triple-stimuli-responsive drug release with magnetic resonance imaging.
Lin X; Song X; Zhang Y; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Biomater Sci; 2020 Mar; 8(7):1875-1884. PubMed ID: 32010912
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
10. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging.
Bigaj-Józefowska MJ; Coy E; Załęski K; Zalewski T; Grabowska M; Jaskot K; Perrigue P; Mrówczyński R; Grześkowiak BF
J Photochem Photobiol B; 2023 Dec; 249():112813. PubMed ID: 37977004
[TBL] [Abstract][Full Text] [Related]
12.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
14. Tumor-targeting multi-functional nanoparticles for theragnosis: new paradigm for cancer therapy.
Ryu JH; Koo H; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
Adv Drug Deliv Rev; 2012 Oct; 64(13):1447-58. PubMed ID: 22772034
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers.
Talluri S; Malla RR
Curr Drug Metab; 2019; 20(12):942-945. PubMed ID: 31622217
[TBL] [Abstract][Full Text] [Related]
16. Indocyanine Green-Based Theranostic Nanoplatform for NIR Fluorescence Image-Guided Chemo/Photothermal Therapy of Cervical Cancer.
Ma R; Alifu N; Du Z; Chen S; Heng Y; Wang J; Zhu L; Ma C; Zhang X
Int J Nanomedicine; 2021; 16():4847-4861. PubMed ID: 34305398
[TBL] [Abstract][Full Text] [Related]
17. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
18. From one to all: self-assembled theranostic nanoparticles for tumor-targeted imaging and programmed photoactive therapy.
Li X; Wang X; Zhao C; Shao L; Lu J; Tong Y; Chen L; Cui X; Sun H; Liu J; Li M; Deng X; Wu Y
J Nanobiotechnology; 2019 Feb; 17(1):23. PubMed ID: 30711005
[TBL] [Abstract][Full Text] [Related]
19. Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles.
Satpathy M; Wang L; Zielinski RJ; Qian W; Wang YA; Mohs AM; Kairdolf BA; Ji X; Capala J; Lipowska M; Nie S; Mao H; Yang L
Theranostics; 2019; 9(3):778-795. PubMed ID: 30809308
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional tumor-targeted PLGA nanoparticles delivering Pt(IV)/siBIRC5 for US/MRI imaging and overcoming ovarian cancer resistance.
Zhang Y; Dong Y; Fu H; Huang H; Wu Z; Zhao M; Yang X; Guo Q; Duan Y; Sun Y
Biomaterials; 2021 Feb; 269():120478. PubMed ID: 33213862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
